drugset / Trial / NCT03404843

Red Blood Cell ATP Release and Vascular Function in Humans

NCT03404843

Phase 2 Completed 31 enrolled Colorado State University
RandomizedCrossoverTriple-blindBasic science

Summary

Previous work demonstrates that the red blood cells of older adults do not release a potent vasodilator (ATP) as well as the red blood cells of younger adults. The investigators are targeting a pathway within the red blood cell using fasudil hydrochloride to determine if both the release of ATP from red blood cells and blood flow responses to low oxygen (hypoxia) and exercise in older adults can be improved.

Timeline

Start
2017-07-14
Primary completion
2018-10-05
Completion
2018-10-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Fasudil Small molecule 60 mg Intravenous